G. Dolan

3.4k total citations
93 papers, 2.4k citations indexed

About

G. Dolan is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, G. Dolan has authored 93 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Hematology, 26 papers in Genetics and 13 papers in Molecular Biology. Recurrent topics in G. Dolan's work include Hemophilia Treatment and Research (61 papers), Blood Coagulation and Thrombosis Mechanisms (31 papers) and Platelet Disorders and Treatments (17 papers). G. Dolan is often cited by papers focused on Hemophilia Treatment and Research (61 papers), Blood Coagulation and Thrombosis Mechanisms (31 papers) and Platelet Disorders and Treatments (17 papers). G. Dolan collaborates with scholars based in United Kingdom, Germany and Spain. G. Dolan's co-authors include Cédric Hermans, Massimo Morfini, Thierry Lambert, Rolf Ljung, Víctor Jiménez‐Yuste, Gary Benson, Brian O’Mahony, Anne Duffy, Philippe de Moerloose and Robert Klamroth and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and American Journal of Obstetrics and Gynecology.

In The Last Decade

G. Dolan

91 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Dolan United Kingdom 27 1.8k 533 282 218 178 93 2.4k
Nongnuch Sirachainan Thailand 22 835 0.5× 551 1.0× 260 0.9× 192 0.9× 246 1.4× 136 1.6k
Jerome Teitel Canada 23 1.2k 0.6× 324 0.6× 146 0.5× 96 0.4× 164 0.9× 81 1.6k
Rachael F. Grace United States 22 1.7k 0.9× 471 0.9× 103 0.4× 158 0.7× 307 1.7× 109 2.3k
Joyce Curvers Netherlands 24 1.1k 0.6× 239 0.4× 203 0.7× 317 1.5× 130 0.7× 41 1.9k
Guglielmo Mariani Italy 21 1.5k 0.8× 343 0.6× 115 0.4× 131 0.6× 195 1.1× 55 2.0k
Yahya Büyükaşık Türkiye 20 818 0.5× 357 0.7× 246 0.9× 113 0.5× 130 0.7× 164 1.6k
Darla Liles United States 16 870 0.5× 747 1.4× 210 0.7× 47 0.2× 153 0.9× 75 1.6k
Renu Saxena India 21 967 0.5× 417 0.8× 133 0.5× 100 0.5× 81 0.5× 123 1.3k
Anoop Enjeti Australia 21 905 0.5× 252 0.5× 792 2.8× 225 1.0× 117 0.7× 75 1.6k
José Ramón González‐Porras Spain 25 1.1k 0.6× 280 0.5× 231 0.8× 47 0.2× 370 2.1× 102 1.8k

Countries citing papers authored by G. Dolan

Since Specialization
Citations

This map shows the geographic impact of G. Dolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Dolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Dolan more than expected).

Fields of papers citing papers by G. Dolan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Dolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Dolan. The network helps show where G. Dolan may publish in the future.

Co-authorship network of co-authors of G. Dolan

This figure shows the co-authorship network connecting the top 25 collaborators of G. Dolan. A scholar is included among the top collaborators of G. Dolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Dolan. G. Dolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blatný, Jan, Cristina Catarino, G. Dolan, et al.. (2024). Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions. Therapeutic Advances in Hematology. 15. 1574202903–1574202903.
2.
St‐Louis, Jean, Pratima Chowdary, G. Dolan, et al.. (2022). Multidisciplinary Team Care of Patients with Hemophilic Arthropathy: A Qualitative Assessment of Contemporary Practice in the UK and Canada. Clinical and Applied Thrombosis/Hemostasis. 28. 2975251506–2975251506. 6 indexed citations
3.
O’Mahony, Brian, G. Dolan, Diane J. Nugent, & Clifford Goodman. (2018). Patient‐centred value framework for haemophilia. Haemophilia. 24(6). 873–879. 21 indexed citations
4.
Dolan, G., Gary Benson, Anne Duffy, et al.. (2017). Haemophilia B: Where are we now and what does the future hold?. Blood Reviews. 32(1). 52–60. 37 indexed citations
5.
James, Paula, Raj S. Kasthuri, Rebecca Kruse‐Jarres, et al.. (2013). Global Emerging HEmophilia Panel (GEHEP): A Multinational Collaboration for Advancing Hemophilia Research and Treatment. Transfusion Medicine and Hemotherapy. 40(5). 352–355. 4 indexed citations
6.
Colvin, B T, G. Dolan, Carlo Martinoli, & Brian O’Mahony. (2013). Pfizer‐sponsored satellite symposium at the European Haemophilia Consortium (EHC) congress. Understanding health outcomes: focus on haemophilia. European Journal Of Haematology. 90(s73). 1–9. 2 indexed citations
7.
Moerloose, P de, et al.. (2012). Acute coronary syndromes in persons with hemophilia - comments on ESC guidelines by the ADVANCE working group. Haemophilia. 18. 24–24. 1 indexed citations
8.
Dolan, G., Elisabeth Steinhagen‐Thiessen, Craig M. Kessler, et al.. (2012). Advances in Hemophilia Care: Report of Two Symposia at the Hemophilia 2010 World Congress. Advances in Therapy. 29(S1). 1–16. 2 indexed citations
9.
10.
Clemens, Andreas, Herbert Noack, Paul Robinson, et al.. (2009). Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism in patients aged over 75 years or with moderate renal impairment undergoing total knee or hip replacement. Thrombosis and Haemostasis. 103(2). 360–371. 29 indexed citations
11.
Perry, David J., Erik Berntorp, Robert C. Tait, et al.. (2009). FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations. Haemophilia. 16(1). 80–89. 20 indexed citations
12.
Wolowacz, Sorrel, S Beard, Paul A. Robinson, et al.. (2009). Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery. Clinical Therapeutics. 31(1). 194–212. 61 indexed citations
13.
Oldenburg, Johannes, G. Dolan, & G. Lemm. (2008). Haemophilia care then, now and in the future. Haemophilia. 15(s1). 2–7. 55 indexed citations
14.
Richards, Michael, Carmen Altisent, Angelika Bátorová, et al.. (2007). Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data. Haemophilia. 13(5). 473–479. 54 indexed citations
15.
Dolan, G., et al.. (2005). The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders. American Journal of Obstetrics and Gynecology. 193(4). 1361–1363. 42 indexed citations
16.
Hill, Marian, et al.. (2005). Genetic analysis in FXI deficiency: six novel mutations and the use of a polymerase chain reaction‐based test to define a whole gene deletion. British Journal of Haematology. 129(6). 825–829. 10 indexed citations
17.
Newland, Adrian C., Jamie Cavenagh, A. Copplestone, et al.. (2001). Vigam‐S, a solvent/detergent‐treated intravenous immunoglobulin, in idiopathic thrombocytopenic purpura. Transfusion Medicine. 11(1). 37–44. 15 indexed citations
18.
Scobie, Graeme, et al.. (1996). Development of a rapid DNA screening procedure for the Factor V Leiden mutation. Molecular Pathology. 49(6). M361–M363. 8 indexed citations
19.
Dolan, G., et al.. (1993). Interaction of hepatitis B and hepatitis C infection in haemophilia. British Journal of Haematology. 85(3). 611–612. 20 indexed citations
20.
Dolan, G., M. Greaves, P. Cooper, & F E Preston. (1988). Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds. British Journal of Haematology. 70(4). 417–421. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nongnuch Sirachainan Breakdown of academic impact, for papers by Jerome Teitel Breakdown of academic impact, for papers by Rachael F. Grace Breakdown of academic impact, for papers by Joyce Curvers Breakdown of academic impact, for papers by Guglielmo Mariani Breakdown of academic impact, for papers by Yahya Büyükaşık Breakdown of academic impact, for papers by Darla Liles Breakdown of academic impact, for papers by Renu Saxena Breakdown of academic impact, for papers by Anoop Enjeti Breakdown of academic impact, for papers by José Ramón González‐Porras
Rankless by CCL
2026